These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23777425)

  • 1. Do CDKN2 p16 540 C>G, CDKN2 p16 580 C>T, and MDM2 SNP309 T>G gene variants act on colorectal cancer development or progression?
    Tuna G; Küçükhüseyin O; Arıkan S; Kaytan Sağlam E; Güler E; Cacına C; Oztop O; Turan S; Korkmaz G; Yaylım I
    DNA Cell Biol; 2013 Jul; 32(7):400-8. PubMed ID: 23777425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
    Kafadar A; Küçükhüseyin Ö; Turan S; Yenilmez EN; Tunoglu S; Zeybek U; Kaynar MY; Kemerdere R; Yaylim I
    Anticancer Res; 2015 Jul; 35(7):3933-42. PubMed ID: 26124340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan.
    Yueh TC; Hung YW; Shih TC; Wu CN; Wang SC; Lai YL; Hsu SW; Wu MH; Fu CK; Wang YC; Ke TW; Chang WS; Tsai CW; Bau DT
    Cancer Genomics Proteomics; 2018; 15(5):405-411. PubMed ID: 30194081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer.
    Zhang X; Pageon L; Post SM
    Oncogene; 2015 Aug; 34(33):4412-20. PubMed ID: 25435368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
    Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 SNP309 polymorphism is associated with colorectal cancer risk.
    Wang W; Du M; Gu D; Zhu L; Chu H; Tong N; Zhang Z; Xu Z; Wang M
    Sci Rep; 2014 May; 4():4851. PubMed ID: 24797837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Int J Cancer; 2007 Feb; 120(3):563-5. PubMed ID: 17096342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.
    Walsh CS; Miller CW; Karlan BY; Koeffler HP
    Gynecol Oncol; 2007 Mar; 104(3):660-4. PubMed ID: 17123590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
    Abderrahmane R; Louhibi L; Moghtit FZ; Boubekeur A; Benseddik K; Boudjema A; Benrrahal F; Aberkane M; Fodil M; Saidi-Mehtar N
    Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancer.
    Hitzenbichler F; Stoehr CG; Rogenhofer M; Wieland WF; Ruemmele P; Hartmann A; Stoehr R
    Pathobiology; 2014; 81(2):53-9. PubMed ID: 24217660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of
    Turgut S; Ilhan M; Turan S; Karaman O; Yaylim I; Kucukhuseyin O; Tasan E
    In Vivo; 2017; 31(3):357-363. PubMed ID: 28438863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome.
    Sotamaa K; Liyanarachchi S; Mecklin JP; Järvinen H; Aaltonen LA; Peltomäki P; de la Chapelle A
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6840-4. PubMed ID: 16203772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.
    Menin C; Scaini MC; De Salvo GL; Biscuola M; Quaggio M; Esposito G; Belluco C; Montagna M; Agata S; D'Andrea E; Nitti D; Amadori A; Bertorelle R
    J Natl Cancer Inst; 2006 Feb; 98(4):285-8. PubMed ID: 16478747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck.
    Alhopuro P; Ylisaukko-Oja SK; Koskinen WJ; Bono P; Arola J; Järvinen HJ; Mecklin JP; Atula T; Kontio R; Mäkitie AA; Suominen S; Leivo I; Vahteristo P; Aaltonen LM; Aaltonen LA
    J Med Genet; 2005 Sep; 42(9):694-8. PubMed ID: 16141004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study.
    Assmann G; Voswinkel J; Mueller M; Bittenbring J; Koenig J; Menzel A; Pfreundschuh M; Roemer K; Melchers I
    Clin Exp Rheumatol; 2009; 27(4):615-9. PubMed ID: 19772793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
    Fu Q; Zhang G; Chen H; Zheng Y; Cheng J
    Tumour Biol; 2013 Dec; 34(6):3721-9. PubMed ID: 23912932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between MDM2 SNP309 polymorphism and endometrial cancer risk in Polish women.
    Zając A; Stachowiak G; Pertyński T; Romanowicz H; Wilczyński J; Smolarz B
    Pol J Pathol; 2012 Dec; 63(4):278-83. PubMed ID: 23359199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.